Sign inGet started

Kelly Leanne M.

Insider CIK 1398278 · VLON Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GRI GRI Bio, Inc. A Award deriv2025-09-182025-09-2243,222— $043,222SEC↗
GRI GRI Bio, Inc. A Award deriv2025-08-262025-08-2711,854— $011,854SEC↗
GRI GRI Bio, Inc. A Award deriv2025-01-232025-01-2443,319$0.69 $29.9K43,319SEC↗
GRI GRI BIO, Inc. A Award deriv2023-09-222023-09-2683,333$1.52 $126.7K83,333SEC↗
VLON Vallon Pharmaceuticals, In A Award deriv2022-02-152022-03-0150,000$5.63 $281.5K50,000SEC↗
VLON Vallon Pharmaceuticals, In P Buy2021-06-042021-06-041,508$4.08 $6.2K6,250SEC↗
VLON Vallon Pharmaceuticals, In P Buy2021-06-032021-06-041,085$4.05 $4.4K4,742SEC↗
VLON Vallon Pharmaceuticals, In P Buy2021-06-022021-06-043,657$4.00 $14.6K3,657SEC↗
VLON Vallon Pharmaceuticals, In A Award deriv2021-05-142021-05-1870,000— $070,000SEC↗